Skip to main content

Table 1 Demographic characteristics, clinical and functional assessment by CMR

From: Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance

 

Clinical phases

Total

p

Indeterminate

CPND

CPD

(n = 16)

(n = 17)

(n = 21)

(n = 54)

Age

57.8 ± 11.9

54.3 ± 10.3

54.7 ± 11.3

55.5 ± 11.1

0.61

Male

3 (18.7 %)

7 (41.1 %)

16 (76.1 %)

26 (48.1 %)

0.02

FC NYHA = I

16 (100 %)

14 (82.4 %)

1 (4.8 %)

31 (57.4 %)

<0.001

FC NYHA > I

0 (0)

3 (17.6 %)

20 (95.2 %)

23 (42.6 %)

<0.001

RVEDVi (ml/m2)

67.7 ± 14.9

70.4 ± 12.2

78.0 ± 22.7

72.6 ± 18.0

0.19

RVESVi (ml/m2)

25.9a ± 5.6

32.0 ± 9.1

40.8a ± 21.7

33.6 ± 15.8

0.01

RVEF (%)

60.9a ± 7.1

54.7 ± 7.9

49.2a ± 12.8

54.4 ± 10.9

0.04

LVEDVi (ml/m2)

72.0a ± 15.4

84.6b ± 22.7

137.0a, b ± 44.0

101.4 ± 42.6

<0.001

LVESVi (ml/m2)

24.9a ± 6.3

39.7b ± 19.5

90.4a, b ± 42.3

55.0 ± 40.6

<0.001

LVEF (%)

65.0a ± 5.7

54.0a ± 12.0

35.8a ± 10.8

50.2 ± 15.8

<0.001

Mass index(g/m2)

55.2a ± 10.5

70.9 ± 15.8

82.2a ± 27.6

70.6 ± 22.8

0.01

  1. Data are expressed as mean ± SD for numeric variables or absolute and relative frequencies (%) for categorical variables
  2. CPND cardiac phase without left ventricular systolic dysfunction, CPD cardiac phase with left ventricular systolic dysfunctional. LV left ventricle, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, RV right ventricle. FC functional class, NYHA New York Heart Association
  3. Difference by post hoc analysis (a, b)